ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP.
Sign Up to like & getrecommendations! Published in 2020 at "Blood advances"
DOI: 10.1182/bloodadvances.2020001987
Abstract: Introduction of the nanobody caplacizumab was shown to be effective in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in the acute setting. The official recommendations include plasma exchange (PEX), immunosuppression, and the use of… read more here.
Keywords: adamts13 activities; treatment; caplacizumab treatment; caplacizumab ... See more keywords